Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogennews2022-12-29T19:54:35+00:00December 29th, 2022|The New York Times|
Drug Plan Fails, Signaling Thorny Path for Democrats’ $3.5 Trillion Billnews2021-09-16T00:32:25+00:00September 16th, 2021|The New York Times|
Democratic Divisions Flare Over Tax Increases and Drug Pricingnews2021-09-15T00:55:52+00:00September 15th, 2021|The New York Times|
House Committees Demand F.D.A. Records on Alzheimer’s Drug Approvalnews2021-09-02T17:20:46+00:00September 2nd, 2021|The New York Times|